Epidemiology of Non-Hodgkin Lymphoma

被引：46
|
作者：
Skrabek, Pamela [1 ,2 ]
Turner, Donna [2 ,3 ]
Seftel, Matthew [1 ]
机构：
[1] CancerCare Manitoba, Dept Med Oncol & Haematol, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada
[3] CancerCare Manitoba, Epidemiol & Canc Registry, Winnipeg, MB, Canada
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2013年 / 49卷 / 02期
关键词：
Epidemiology; Etiology; Non-Hodgkin Lymphoma (NHL); POOLED ANALYSIS; RISK-FACTORS; CONSORTIUM INTERLYMPH; INCREASING INCIDENCE; SUN EXPOSURE; COHORT; METAANALYSIS; CANCER; AIDS; COUNTRIES;
D O I：
10.1016/j.transci.2013.07.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Non-Hodgkin Lymphoma (NHL) occurs worldwide although there is notable geographical variation in incidence and subtype distribution. These differences are due to a combination of demographic, environmental and other unidentified factors. A dramatic increase in NHL incidence was seen starting around 1970, with subsequent stabilization 10 years ago. Despite this plateau, the number of new cases in many countries will increase significantly in coming years due primarily to aging populations. In the majority of cases, strong risk factors are not identifiable. There is significant epidemiological heterogeneity between NHL subtypes, yet cancer registries have tended to consider NHL as a single entity. This is one of several epidemiological obstacles discussed. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：133 / 138
页数：6
相关论文
共 50 条
  • [21] Non-Hodgkin lymphoma
    Shankland, Kate R.
    Armitage, James O.
    Hancock, Barry W.
    LANCET, 2012, 380 (9844): : 848 - 857
  • [22] Non-Hodgkin lymphoma
    Evans, LS
    Hancock, BW
    LANCET, 2003, 362 (9378): : 139 - 146
  • [23] Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes
    Smedby, Karin E.
    Hjalgrim, Henrik
    SEMINARS IN CANCER BIOLOGY, 2011, 21 (05) : 293 - 298
  • [24] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
    Bei Hu
    Ryan Jacobs
    Nilanjan Ghosh
    Current Hematologic Malignancy Reports, 2018, 13 : 543 - 554
  • [25] Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
    Hu, Bei
    Jacobs, Ryan
    Ghosh, Nilanjan
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 543 - 554
  • [26] Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors
    Zhumei Zhan
    Wei Guo
    Xin Wan
    Ou Bai
    Annals of Hematology, 2023, 102 : 249 - 259
  • [27] Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors
    Zhan, Zhumei
    Guo, Wei
    Wan, Xin
    Bai, Ou
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 249 - 259
  • [28] Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma
    Moslehi, Roxana
    Coles, F. Bruce
    Schymura, Maria J.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2011, 6 (02) : 175 - 180
  • [29] Epidemiology of Non-Hodgkin Lymphoma: Global Patterns of Incidence, Mortality, and Trends
    Sedeta, Ephrem
    Ilerhunmwuwa, Nosakhare
    Wasifuddin, Mustafa
    Uche, Ifeanyi
    Hakobyan, Narek
    Perry, Jamal
    Aiwuyo, Henry
    Abowali, Hesham
    Avezbakiyev, Boris
    BLOOD, 2022, 140 : 5234 - 5235
  • [30] Non-Hodgkin's malignant lymphoma: Descriptive Epidemiology and risk factors
    Abdellah, BenKhali
    Houria, Ouazzani Chahed
    Abdelmajid, Soulaymani
    Ali, Quyou
    BIOSCIENCE RESEARCH, 2019, 16 (04): : 4006 - 4012
12345